Measures of outcome for stimulant trials: ACTTION recommendations and research agenda
BD Kiluk, KM Carroll, A Duhig, DE Falk… - Drug and alcohol …, 2016 - Elsevier
Background The development and approval of an efficacious pharmacotherapy for stimulant
use disorders has been limited by the lack of a meaningful indicator of treatment success,
other than sustained abstinence. Methods In March, 2015, a meeting sponsored by
Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities,
and Networks (ACTTION) was convened to discuss the current state of the evidence
regarding meaningful outcome measures in clinical trials for stimulant use disorders …
use disorders has been limited by the lack of a meaningful indicator of treatment success,
other than sustained abstinence. Methods In March, 2015, a meeting sponsored by
Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities,
and Networks (ACTTION) was convened to discuss the current state of the evidence
regarding meaningful outcome measures in clinical trials for stimulant use disorders …
Bestes Ergebnis für diese Suche Alle Ergebnisse